Company / PP&E (Net)
Cyclerion Therapeutics, Inc. PP&E (Net) History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
-
FY2024
5-year range
$0 / $65.0K
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Remained stable around $0 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak pp&e (net) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0 | - |
| FY2023 | $0 | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $65.0K | -99.1% |
| FY2020 | $6.9M | -40.9% |
| FY2019 | $11.6M | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026